Robert Ruffolo
@robertruffolo
Director
Building X-Vax Technology, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
X-Vax Technology, Inc. was founded in 2015 and has no closure on record.
Named alongside
- Allen NissensonDirector
- Allen R. NissensonDirector
- Brian PiekosExecutive Officer
- Carol AsheDirector
- Christopher HaqqExecutive Officer
- Gil R. OmennDirector
- Itzhak D. GoldbergExecutive Officer, Director
- Jay D. VenkatesanChief Executive Officer
At Aridis Pharmaceuticals, Inc.
- Craig GibbsDirector
- Craig K. GibbsDirector
- Eric PatzerDirector
- Fred KurlandChief Financial Officer
- Isaac BlechDirector
- Isaac R. BlechDirector
- John HamiltonDirector
- John K. HamiltonDirector
- David ZacardelliDirector
- Edward RosenChief Executive Officer
- Eliel BayeverExecutive Officer
- Gary SenderDirector
- Geno GermanoChief Executive Officer
- Gregory AdamsExecutive Officer
- ISAAC A. BLECHDirector
- Isaac BlechDirector
Contribution
Robert's ideas, decisions and failures appear here once this profile is claimed.
Companies
- X-Vax Technology, Inc.Director · Biotechnology · NEW YORK, United States · Founded 2015
- Vedantra Pharmaceuticals, Inc.Pharmaceutical Preparations; formerly Vedantra Pharmaceuticals, Inc.; filing with the SEC since 2012Director · Biotechnology · Cambridge, United States
- Elucida Oncology, Inc.Director · Biotechnology · NEW YORK, United States · Founded 2014
- LB PHARMACEUTICALS INC.Pharmaceutical Preparations; formerly LB PHARMACEUTICALS INC.; listed on Nasdaq as LBRX; filing with the SEC since 2016Director · Pharmaceuticals · NEW YORK, United States · Founded 2015
- Sapience Therapeutics, Inc.Director · Biotechnology · Scarsdale, United States · Founded 2015
- Nacuity Pharmaceuticals, Inc.Director · Pharmaceuticals · FORT WORTH, United States
- Aridis Pharmaceuticals, Inc.Pharmaceutical Preparations; filing with the SEC since 2014Director · Pharmaceuticals · SAN JOSE, United States
- Angion Biomedica Corp.Pharmaceutical Preparations; formerly Angion Biomedica Corp.; listed on Nasdaq as ELTX; filing with the SEC since 2014Director · Biotechnology · UNIONDALE, United States